InnoCare Pharma (HKG:9969, SHA:688428) posted 409.3 million yuan in net profit attributable to shareholders of the listed company for the third quarter, compared with an attributable net loss a year ago.

The pharmaceutical company's Hong Kong and Shanghai shares both fell 2% during Tuesday's afternoon trade.

EPS was 0.24 yuan, a Monday filing with the Hong Kong Stock Exchange showed.

For the three months ended Sept. 30, operating revenue was 962 million yuan, up 151% from a year ago, the company said.